A fascinating new study demonstrates that bone regeneration is not just about osteoblasts—it requires coordinated neurovascular reconstruction. Researchers engineered a multifunctional scaffold that simultaneously activates integrin β1 (ITGB1) through both extracellular ("outside-in") and intracellular ("inside-out") mechanisms, creating a regenerative niche where blood vessels, nerves, and bone form together. 🦴 Key innovation: The PTPG scaffold combines: • REDV–IKVAV peptide → activates endothelial and Schwann cell integrin β1 from outside • Talin1 plasmid delivery → activates integrin β1 from inside • 3D-printed PLA-HA scaffold → structural bone support • GelMA hydrogel → sustained release platform Together, these components create bidirectional ITGB1 activation. Why does this matter? Most bone grafts focus on osteogenesis alone. But large segmental defects require: 🩸 Angiogenesis ⚡ Neurogenesis 🦴 Osteogenesis working as an integrated system. The authors show that vascular endothelial cells and Schwann cells communicate through paracrine signaling, producing VEGF, HIF-1α, NGF, and BDNF that ultimately drive osteoblast differentiation and bone formation. Major findings: ✅ Enhanced endothelial migration and tube formation ✅ Increased Schwann-cell neurotrophic activity ✅ Robust H-type vessel formation (CD31⁺ EMCN⁺) ✅ Aligned neurovascular networks ✅ Greater bone volume and trabecular number ✅ Near-complete healing of critical-sized femoral defects ✅ Activation of the ITGB1–FAK–Paxillin signaling axis ✅ Single-cell RNA-seq confirms enrichment of pro-regenerative endothelial and Schwann-cell states Perhaps the most interesting concept is the emergence of a neurovascular unit for bone repair. Rather than treating blood vessels and nerves as separate targets, the scaffold promotes synchronized vessel–nerve growth, which then guides osteogenesis. This represents a shift from: "bone regeneration" to "neurovascularized organ-level regeneration." The broader implication is that integrin β1 may function as a master coordinator linking vascular, neural, and skeletal repair programs. A compelling example of how regenerative medicine is moving toward engineering entire tissue ecosystems rather than single cell types. Reference Wu F, An Y, Zhao Y et al. Bidirectional integrin β1 activation synergizes neurovascular coupling and enhances bone regeneration. Nature Communications (2026). #RegenerativeMedicine #BoneRegeneration #Integrin #Biomaterials #TissueEngineering #NeurovascularCoupling #SingleCell #NatureCommunications #Bioengineering #TranslationalMedicine

Scaffolds are becoming active medicine. 3D printed scaffolds are moving from “cell holders” to engineered microenvironments. The market was $909M in 2024 and is projected to pass $2B by 2033 [1]. 2025 work now targets degradation, angiogenesis, immunity and even tumor control plus bone repair [2][3] 🧬 This is industrial strategy: orthopedics, wound care, and biomanufacturing jobs will cluster where hospitals, regulators, and GMP suppliers move together. Build standards, reimbursement paths, and clinician-engineer teams early ⚙️ 🤔 What will slow adoption most: biology, regulation, or manufacturing discipline? [1] [grandviewresearch.com/indust…](grandviewresearch.com/indust…) [2] [frontiersin.org/articles/10.…](frontiersin.org/articles/10.…) [3] [nature.com/articles/s41467-0…](nature.com/articles/s41467-0…) #TissueEngineering #3DPrinting #RegenerativeMed #MedTech

Researchers show #PTHrP guides BMP2-driven #MesenchymalStemCells toward #chondrogenesis while delaying hypertrophy and ossification via #Sox9 activation and PI3K–AKT inhibition, advancing cartilage–bone #TissueEngineering. @CQMU1956 #OpenAccess: doi.org/10.1016/j.gendis.202…

💥Excited for the publication: "Large-Scale Expansion of Suspension Cells in an Automated Hollow-Fiber Perfusion Bioreactor" 🔗brnw.ch/21x3idj 📌 #Bioreactors #CellCulture #Biomanufacturing #CellTherapy #TissueEngineering #Biotechnology #RegenerativeMedicine

News How a Revolutionary Cancer Treatment Could Reset the Immune Systems of Patients With Autoimmune Diseases smithsonianmag.com/innovatio… #news #science #autoimmunediseases #bioengineering #biomedical #biotechnology #CART #cells #celltherapy #regenerativemedicine #tissueengineering

🧪 Part of our research journey with students and collaborators on Advanced Wound Dressings Enabled by 3D Printing & Electrospinning. Thread 👇 #WoundHealing #WoundDressings #3DPrinting #Electrospinning #Biomaterials #TissueEngineering #RegenerativeMedicine #Biomedical

🎓 PhD Opportunity in Bone Organoids 🇨🇭 | ETH Zurich 📌 Position: PhD Researcher – Bone Organoids 🏫 University: ETH Zurich 📍 Location: Zurich, Switzerland 🇨🇭 (Singapore-ETH Centre collaboration) 🏢 Department: Future Health Technologies II (FHT II) 👨‍🏫 Supervisor: Prof. Dr. Ralph Müller 📅 Deadline: Not specified ⏳ Duration: ~3–4 years 🔬 About the Project This PhD focuses on developing advanced patient-derived 3D bone organoids to better understand osteoporosis and fracture risk. The project aims to bridge experimental biology and computational modelling by creating human-relevant in vitro systems that capture patient-specific differences in bone remodelling, inflammation, and mechanical responses. These models will support more personalised approaches to musculoskeletal care and fracture prevention. Key research areas include: • 3D bioprinting and tissue engineering of bone organoids • Osteoporosis research and bone remodelling dynamics • Immune–bone interactions and inflammation • Predictive modelling for fracture risk and precision medicine This is a highly interdisciplinary project involving collaboration between engineers, clinicians, biologists, and computational researchers across Switzerland and Singapore. 👤 Ideal Candidate • MSc in biomedical engineering or related field • Experience in tissue engineering and mammalian cell culture • Knowledge of 3D cell culture, organoids, or musculoskeletal research (plus) • Familiarity with molecular, imaging, and biochemical techniques • Interest in precision medicine and skeletal research • Motivated, independent, and collaborative mindset • Fluent in English 🌟 Why Apply? • Work on cutting-edge organoid and regenerative medicine research • Contribute to personalised healthcare solutions for osteoporosis • Collaborate in a diverse, international research environment • Access interdisciplinary expertise across biology, engineering, and computation • Strong networking opportunities across academia and industry 🌍 Location Highlight – Zurich / Singapore This project combines ETH Zurich’s world-class research environment with the dynamic, multicultural setting of the Singapore-ETH Centre—offering a unique global research experience. 🔗 More Info: phdscanner.com/opportunities… #PhD #BiomedicalEngineering #Organoids #TissueEngineering #Osteoporosis #PrecisionMedicine #ETHZurich #Switzerland #ResearchOpportunity #LifeSciences

A Novel #ChitosanModified #PLADoped n-HA #Bone #Scaffold 👉tinyurl.com/yp2vsema #JiamusiUniversity 🇨🇳 | #ArtificialOrgans #Biomaterials #TissueEngineering #RegenerativeMedicine

💥Check out our Editor's Choice publication: "Comparison of 2D, 3D In Vitro, and Ex Vivo Platforms for Modeling the Rat Small Intestine" 🔗 brnw.ch/21x3dEO 📌 #TissueEngineering #Bioelectronics #DrugScreening #BiomedicalEngineering #InVitroModels #TranslationalResearch

💥Check out our Editor's Choice publication: "Beyond Decellularization: Remnant Mitochondrial DNA Can Act as Hidden Damage-Associated Molecular Pattern" 🔗 brnw.ch/21x3bEG 📌 #RegenerativeMedicine #TissueEngineering #Biomaterials #Immunology #Bioengineering

Can #DrugDeliverySystems #Biomaterials enable smarter #TissueEngineering for regeneration? Biotech-derived DDS (proteins & polysaccharides) enable controlled release & ECM-mimic scaffolds. Read 👉imrpress.com/journal/FBE/18/… #TissueEngineering #DrugDeliverySystems #FBE

The closer a biomaterial resembles native tissue, the better it can support regeneration. That's one reason Type II collagen is so valuable in cartilage applications. #TissueEngineering #TypeIICollagen

Bone repair is becoming a materials race. In 2025, bone grafts and substitutes are a $3.34B market, projected to hit $5.50B by 2033 [1]. But the real shift is scientific: 3D-printed scaffolds now aim to mimic native bone architecture, while bioactive ceramics, polymers and hydrogels are moving from “fill the gap” to “signal the body to rebuild” 🦴 [2]. This matters because aging populations, trauma care and dental reconstruction are colliding with pressure on hospitals to reduce revisions, donor-site morbidity and supply fragility. Regions that master biomaterials manufacturing will own more than patents; they’ll own clinical competitiveness ⚙️. The challenge: regulators, surgeons and manufacturers must align earlier, or great lab materials will keep dying in translation [3]. 🤔 Where do you disagree: should bone regeneration prioritize biological performance, manufacturability, or regulatory simplicity first? [1] [grandviewresearch.com/indust…](grandviewresearch.com/indust…) [2] [frontiersin.org/journals/bio…](frontiersin.org/journals/bio…) [3] [nature.com/articles/s44222-0…](nature.com/articles/s44222-0…) #BoneRegeneration #Biomaterials #MedTech #TissueEngineering

@EuTermis 2026 was a blast! Connecting with colleagues, collaborators, and my dear friend #DenitzaDoceva in Palma de Mallorca! #TERMIS2026 #RegenerativeMedicine #TissueEngineering #Biofabrication #HealthcareInnovation #ClinicalTranslation

🦴 Bone-on-a-Chip Is Redefining Bone Biology Research Microengineered Bone Models: Advances and Applications of Bone-on-a-Chip Technology 📖 Journal of Biological Engineering (2026) 🔗 DOI: 10.1186/s13036-026-00703-3 For decades, bone research has relied on a trade-off: 🔬 2D cultures are scalable but physiologically unrealistic. 🐭 Animal models capture complexity but often fail to predict human responses. A new comprehensive review highlights how Bone-on-a-Chip (BoC) technology is emerging as a powerful bridge between these worlds. By combining microfluidics, biomaterials, tissue engineering, and real-time sensing, BoC systems aim to recreate the dynamic bone microenvironment in vitro. Why is this important? Bone is not simply a mineralized scaffold. It is a living organ composed of: • Osteoblasts (bone formation) • Osteoclasts (bone resorption) • Osteocytes (mechanosensing and remodeling control) • Vascular and marrow niches • Complex mechanical loading forces Replicating these interactions has been extraordinarily difficult using conventional experimental models. Modern BoC platforms now incorporate: ✅ Microfluidic perfusion ✅ 3D mineralized matrices ✅ Osteogenic and hematopoietic compartments ✅ Controlled oxygen gradients ✅ Mechanical stimulation ✅ Real-time biosensors These systems allow investigators to study bone remodeling under conditions that more closely resemble human physiology. One particularly exciting application is bone marrow niche modeling. Recent devices successfully maintain hematopoietic stem and progenitor cells while recreating vascularized marrow microenvironments, enabling studies of hematopoiesis, drug toxicity, and niche biology that were previously difficult to perform in human systems. Another major advance is bone metastasis modeling. Bone is the preferred metastatic site for breast, prostate, and lung cancers. BoC platforms have reproduced critical features of metastatic colonization, including: 🔹 Tumor dormancy 🔹 Perivascular niche interactions 🔹 Oxygen gradients 🔹 Drug resistance mechanisms These models provide unprecedented opportunities to investigate early metastatic events and evaluate anti-metastatic therapies. The review also highlights the growing role of BoC systems in drug discovery. Researchers have developed: • Osteon-mimetic chips for osteoporosis drug screening • AI-assisted image analysis pipelines • Hydroxyapatite-coated microfluidic scaffolds • Personalized bone regeneration platforms using stem cells These advances are moving bone research toward precision medicine. Yet significant challenges remain. Current platforms still struggle to fully reproduce: ❌ Native bone hierarchy ❌ Osteocyte networks ❌ Long-term remodeling cycles ❌ Functional vascularization ❌ Immune system integration ❌ Physiological mechanical loading The next generation of BoC systems will likely integrate multi-organ interactions, patient-derived iPSCs, advanced bioprinting, and AI-powered analytics to create truly predictive human bone models. Bone-on-a-Chip is rapidly evolving from an engineering curiosity into a translational platform that could transform osteoporosis research, cancer metastasis studies, fracture healing, regenerative medicine, and drug development. #BoneOnAChip #OrganOnAChip #BoneBiology #RegenerativeMedicine #Microfluidics #DrugDiscovery #Osteoporosis #BoneMetastasis #TissueEngineering #PrecisionMedicine #Bioengineering #AgingResearch #StemCells #AIinBiology #TranslationalMedicine

💥Excited for the publication: "The Use of Gelatin Methacrylate (GelMA) in Cartilage Tissue Engineering: A Comprehensive Review" 🔗brnw.ch/21x34wt 📌 #CartilageRepair #TissueEngineering #3DBioprinting #Biomaterials #RegenerativeMedicine #Biofabrication #Orthopedics

🚨Our #TissueEngineering and #BiomedicalMaterials research group is offering a position in the development of advanced #biomaterials and fabrication strategies for regenerative medicine applications. 🔗 For conditions and to apply, see: jobs.materials.imdea.org/off… @ScienceCareers

On #immortal #tissue #explants, and why such #research can be of fundamental applied interest. Typically, #aging and the accompanying death of tissue are natural processes of mortality, particularly within the #Deuterostomia, the animal phylum to which we ourselves belong. The capacity for #regeneration is generally poorly developed among deuterostomes, especially in #vertebrates. There are few exceptions—such as feather stars (Echinodermata) or lizards (Lacertidae, Squamata), which are able to regrow tails shed when under threat. Nevertheless, researchers have long been conducting experiments aimed at the indefinite preservation of extracted tissue. To date, however, this has only been successfully achieved using specialized culture media. Yet, the #tissues maintained in such environments exhibit only limited signs of full #functionality. Moreover, they generally lack regenerative capacity and, until now, could only be successfully isolated from embryonic tissue. This type of research is, however, of significant importance, for instance, for the in vitro cultivation of human organs or tissue components, a capability that holds particular relevance for the field of transplant biology. Based on their study of #seacucumbers, authors S. Jobson et al. (2026) have established that the tissues of a specific species remain viable in seawater without the addition of specific cultivar nutrients. The researchers explanted epidermal, connective, nervous, and muscle tissues from the #seacucumber #Psolus #fabricii (#Holothuroidea: #Echinodermata). They designated the explants derived from this sea cucumber species as "#LiPfes" (living, immortal P. fabricii explants). A remarkable feature of this phenomenon is that the tissue remains in an #activestate of #life; it exhibits cell division activity, #woundhealing (regeneration), tissue differentiation, #immuneactivity, and the uptake of dissolved amino acids. These tissue characters are a unique feature of the species P. fabricii; this phenomenon is observed neither in closely related sea cucumber species nor is it known to occur in any other sea cucumbers. Consequently, this sea cucumber #species serves as a significant model organism for the study of aging phenomena and for #tissueengineering. © #StefanFWirth, May 2026, Berlin Please support my work as freelancer in science communication, science writing, scientific research and art, as freelancer, I depend on your donations, thanks so much: ko-fi.com/sfwirth Reference: S. Jobson et al. (2026) : doi.org/10.1126/sciadv.aeb13… Illustrations: © Stefan F. Wirth, May 2026, Berlin, AI assisted artistic illustrations, based on my hand-drawn sketches, manually edited: 1) Diver and three undefined sea cucumber species 2) diver and undefined sea cucumber isolated 3) illustration of Psolus fabricii

🕸️ This systematic review highlights its biocompatibility, tunable biodegradation, and potential to enhance bone healing and drug delivery, particularly in craniofacial applications. 🔗 mdpi.com/2313-7673/9/5/286 #SilkFibroin #Biomaterials #TissueEngineering #SurgicalInnovation

News Growing liver tissue on demand directly in the body wyss.harvard.edu/news/growin… #news #science #3d #bioengineering #biomaterials #biomedical #biomimetic #biotechnology #cells #generegulation #liver #regenerativemedicine #syntheticbiology #tissueengineering #tissueregeneration